TIA supports research acceleration and translation
News

Cancer medicine research advances with TIA expertise
Researchers will use TIA facilities and expertise to advance their work to discover a targeted medicine that boosts the immune system to fight cancer. They

National research infrastructure working together to improve the health of Australians
Innovation in Australia’s health and medical research translation has been boosted with National Collaborative Research Infrastructure Strategy (NCRIS)- enabled health and medical research partners signing

TIA partners with AAMRNet to accelerate therapeutic development research
Research in areas such as cancer, autoimmune disease, endometriosis, mental health, kidney disease and bacterial infection will advance with almost $500,000 in support from Therapeutic

NCRIS: The power behind Australia’s science
Australian science continues to make national and international headlines, most recently focusing on the COVID-19 pandemic and the 2019 – 2020 Australian bushfires. Behind these

🏏 TIA reaches a century of voucher awards! 🏏
We are delighted to announce the outcomes of the first round of Pipeline Accelerator 2021-22 scheme. A total of $560,000 will be invested to support

New role looks at worm saliva to eradicate diabetes
AIBN Professor Trent Munro is part of a new biotechnology company aiming to treat Type 2 diabetes using saliva from parasitic worms. Professor Munro has

New Zealand accessing Australian expertise to build mRNA COVID-19 vaccines
AUCKLAND: COVID-19 Vaccination Corporation (CVC), New Zealand’s most experienced group of vaccine researchers have joined forces with Australia’s BASE Nucleic Acids Biomanufacturing Facility to produce

Pipeline Navigator 2021-22 (Round 1) is now open for applications
TIA supports and facilitates researcher and SME access to a diverse range of Australian translational medical research infrastructure (see Table 1) via a voucher-style scheme

Perkin Elmer and BIF collab to help train local businesses
The Biologics Innovation Facility (BIF) in collaboration with PerkinElmer have established a training facility to assist local biotech companies and academia to have access to